Quality of life after breast reconstruction-the BRIOS study

Affiliations

¹ Bristol Centre for Surgical Research, Population Health Sciences, Bristol Medical School, Bristol, BS8 2PS, UK; Bristol Breast Care Centre, North Bristol NHS Trust, Bristol, UK. Electronic address: shelley.potter@bristol.ac.uk.
² Faculty of Medicine, Cancer Sciences Unit, University of Southampton, Somers Cancer Research Building, University Hospital Southampton, Southampton, UK.
³ Clinical Trials Research Centre (CTRC), University of Liverpool, Liverpool, UK.
⁴ Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospital, Prescot Street, Liverpool, UK.

Comment

Shelley Potter et al. Lancet Oncol. 2018 Nov.

. 2018 Nov;19(11):e577.

doi: 10.1016/S1470-2045(18)30694-6. Epub 2018 Nov 1.

¹ Bristol Centre for Surgical Research, Population Health Sciences, Bristol Medical School, Bristol, BS8 2PS, UK; Bristol Breast Care Centre, North Bristol NHS Trust, Bristol, UK. Electronic address: shelley.potter@bristol.ac.uk.
² Faculty of Medicine, Cancer Sciences Unit, University of Southampton, Somers Cancer Research Building, University Hospital Southampton, Southampton, UK.
³ Clinical Trials Research Centre (CTRC), University of Liverpool, Liverpool, UK.
⁴ Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospital, Prescot Street, Liverpool, UK.

No abstract available

Comment on

Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial.
Negenborn VL, Young-Afat DA, Dikmans REG, Smit JM, Winters HAH, Don Griot JPW, Twisk JWR, Ruhé PQ, Mureau MAM, Lapid O, Moerman E, van Turnhout AAWM, Ritt MJPF, Bouman MB, Mullender MG. Negenborn VL, et al. Lancet Oncol. 2018 Sep;19(9):1205-1214. doi: 10.1016/S1470-2045(18)30378-4. Epub 2018 Aug 10. Lancet Oncol. 2018. PMID: 30104147 Clinical Trial.